个性化护理干预对接受血液净化治疗的尿毒症患者护理满意度评价陈丽

首页 -> 往期阅览-> 2025年

《实用全科护理学》( ISSN3080-7638、EISSN3080-7646 )

发布者：Quest Press

发布日期：2025/10/9

10.12479/questpress-syqkhlx.20250223

Open Access

下载2次

浏览67次

个性化护理干预对接受血液净化治疗的尿毒症患者护理满意度评价

陈丽

淮安市第五人民医院，江苏淮安，223300

摘要：目的探究尿毒症患者血液净化治疗时个性化护理的应用价值。方法根据随机数字表法指导，将 2024 年 2 月至 2025 年 2 月在本院开展血液净化治疗的尿毒症患者分组，具体包括：对照组、实验组，两组共计 100 例；其中，常规护理用于对照组，个性化护理用于实验组，比较效果。结果尿毒症患者情绪状态、PSQI 评分、总有效率、并发症发生率、满意度中，个性化护理后优势明显，P＜0.05。结论血液净化治疗时，个性化护理有确切效果，值得推行。
关健词：尿毒症；血液净化；个性化护理

Evaluation of personalized nursing intervention on the nursing satisfaction of uremic patients receiving blood purification treatment

Li Chen
Huai'an Fifth People's Hospital, Huai'an Jiangsu 223300, China

Abstract: Objective To explore the application value of personalized nursing in blood purification treatment for patients with uremia. Methods According to the guidance of the random number table method, uremic patients who underwent blood purification treatment in our hospital from February 2024 to February 2025 were grouped, specifically including: the control group and the experimental group, with a total of 100 cases in the two groups. Among them, conventional care was used in the control group, and personalized care was used in the experimental group to compare the effects. Results Among the emotional state, PSQI score, total effective rate, complication rate and satisfaction of uremic patients, personalized nursing had a significant advantage (P < 0.05). Conclusion Personalized care has definite effects during blood purification treatment and is worth promoting.
Keywords : Uremia；Blood purification；Personalized care

论文收录证明 / 文献检索报告

Document Retrieval Certificate / Proof of Publication Indexing

作者贡献声明 / 贡献确认书

Author Contribution Statement / Certificate of Authorship Contribution

同行评审报告 / 评审意见

Peer Review Report / Peer Review Comments

利益冲突

Conflict of Interest

作者声明不存在任何利益冲突。

The author declares no conflict of interest.

本文采用知识共享“署名 4.0 国际”许可 (CC BY 4.0) 进行许可。许可协议详情请访问： https://creativecommons.org/licenses/by/4.0/。

This article is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0). For details of the license, please visit:https://creativecommons.org/licenses/by/4.0/.